Kyntra Bio, Inc. (KYNB) — Long-term Investment Intensity
Kyntra Bio, Inc. (KYNB) has a Long-term Investment Intensity of 16.9% as of December 2025. Long-term investments of $20.16 Million represent 16.9% of total assets of $119.59 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Kyntra Bio, Inc. (KYNB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kyntra Bio, Inc. Long-term Investment Intensity (2021–2025)
This chart shows how Kyntra Bio, Inc.'s Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 16.9%, reflecting long-term investments of $20.16 Million against total assets of $119.59 Million USD. Explore cash flow to debt ratio of Kyntra Bio, Inc. to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Kyntra Bio, Inc. (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Kyntra Bio, Inc. from 2021 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see KYNB company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 16.9% | $20.16 Million | $119.59 Million | ▲ +15.6 pp |
| 2023 | 1.2% | $5.29 Million | $423.53 Million | ▼ -0.3 pp |
| 2022 | 1.5% | $9.41 Million | $610.09 Million | ▼ -20.6 pp |
| 2021 | 22.2% | $171.62 Million | $773.82 Million | — |